Status:
COMPLETED
Impact of TECAR in Treatment of Rectus Diastasis
Lead Sponsor:
Cairo University
Conditions:
Rectus Diastasis
Eligibility:
FEMALE
25-35 years
Phase:
NA
Brief Summary
The study aim to evaluate the impact of TECAR treatment on rectus diastasis in postnatal women
Detailed Description
Radiofrequency (RF) is the emission of high frequency waves via an applicator. The transfer of electromagnetic energy stimulates targeted tissues. RF can be used in two ways: capacitive or resistive (...
Eligibility Criteria
Inclusion
- postnatal females suffering from diastasis recti more than 2.5 cm with bulged abdomen,
- Their age ranged from 25 - 35 years.
- Their body mass index (BMI) ranged from 25-35 kg/m2.
- All women delivered normally
Exclusion
- Any participant was excluded if she had any disease that interferes with exercises (asthma), any skin disease or sensitivity that interferes with the application, any chest disease or cardiac disease or women had abdominal surgery.
Key Trial Info
Start Date :
June 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2022
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05287282
Start Date
June 1 2022
End Date
September 30 2022
Last Update
January 12 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kafrelshiesk university hospital
Tanta, Egypt